Compare GM & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GM | COR |
|---|---|---|
| Founded | 1908 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.5B | 68.5B |
| IPO Year | 2010 | 2001 |
| Metric | GM | COR |
|---|---|---|
| Price | $79.06 | $284.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 14 |
| Target Price | $93.86 | ★ $390.62 |
| AVG Volume (30 Days) | ★ 8.0M | 1.4M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.94% | 0.77% |
| EPS Growth | N/A | ★ 5.71 |
| EPS | 2.82 | ★ 11.27 |
| Revenue | $185,019,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $3.56 | $8.89 |
| Revenue Next Year | $2.38 | $6.75 |
| P/E Ratio | $28.00 | ★ $24.94 |
| Revenue Growth | N/A | ★ 9.31 |
| 52 Week Low | $48.87 | $244.82 |
| 52 Week High | $87.62 | $377.54 |
| Indicator | GM | COR |
|---|---|---|
| Relative Strength Index (RSI) | 46.89 | 58.83 |
| Support Level | $76.07 | $285.83 |
| Resistance Level | $84.34 | $326.95 |
| Average True Range (ATR) | 2.58 | 6.13 |
| MACD | -0.54 | 1.68 |
| Stochastic Oscillator | 8.22 | 88.54 |
General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under three segments: GM North America, GM International, and GM Financial. The United States now has four brands instead of eight under old GM. The company regained its US market share leadership in 2022, after losing it to Toyota due to the chip shortage in 2021. 2025 US share was 17.4%, up 60 basis points from 2024. The Cruise autonomous vehicle arm, which GM now owns outright, previously operated driverless geofenced AV robotaxi services in San Francisco and other cities, but after a 2023 accident, GM decided that it will focus on personal AVs. GM Financial became the company's captive finance arm in 2010 via the purchase of AmeriCredit.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.